Nanoparticles in Imaging Technologies
Symposium Chair |
|||||
|
|||||
Invited Speakers |
|||||
|
|
||||
|
|
||||
|
|
||||
Symposium Sessions | ||
Tuesday June 22 | ||
| 3:30 | TechConnect Corporate Partnering | |
| 3:30 | US-Korea TechConnect | |
| 4:00 | Poster Session and TechConnect Expo (4:00 - 6:00) | |
| Environment, Health & Safety | ||
Wednesday June 23 | ||
| 10:00 | Networking Coffee Break | |
| 1:30 | Nanoparticles in Bio Imaging Technologies | |
| 4:00 | Poster Session and TechConnect Expo Reception (4:00 - 6:00) - Expo Hall | |
| 6:00 | TechConnect Innovation Showcase Reception (6:00 - 8:00) - Ballroom 3rd Floor | |
Thursday June 24 | ||
| 8:30 | Keynotes: Transformational Nanotech | |
| 10:00 | TechConnect Innovation Showcase Coffee Break - Ballroom 3rd Floor | |
| 10:30 | EHS: Nanoparticle Interactions, Biocompatibility & Toxicity I | |
| 5:00 | TechConnect Investment Networking Reception - Second Floor | |
Symposium Program | ||
Tuesday June 22 | ||
| Back to Top | ||
| 3:30 | TechConnect Corporate Partnering | Room 207 D |
| Session chair: Marjan Kraak, ETH Zurich, CH | ||
| 3:30 | P&G TechConnect Partnering S. Meller, Procter & Gamble, US | |
| 3:50 | Medtronic TechConnect Partnering G. Muramoto, Medtronic, US | |
| 4:10 | Merck TechConnect Partnering Y. Weiss, Merck, US | |
| 4:30 | GE Healthcare TechConnect Partnering J. DeForrest, GE Healthcare, US | |
| Back to Top | ||
| 3:30 | US-Korea TechConnect | Room 206 A |
| Back to Top | ||
| 4:00 | Poster Session and TechConnect Expo (4:00 - 6:00) | Expo Hall |
| Back to Top | ||
| Environment, Health & Safety | Expo Hall | |
| - | Biological Characterization of Aqueous CdSe/ZnS Quantum Dots A. Nagy, A. Zane, P.K. Dutta, W.J. Waldman, The Ohio State University, US | |
| - | Phagocytizing cells recruitment and activity in response to pulmonary deposition of magnetite particles of different size in nanometer and micrometer ranges L.I. Privalova, B.A. Katsnelson, S.V. Kuzmin, T.D. Degtyareva, M.P. Sutunkova, O.S. Yeremenko, M.Y. Khodos, A.N. Kositsina, N.A. Malakhova, J.A. Glazyrina, Medical Research Center for Prophylaxis and Health Protection in Industrial Workers, RU | |
| - | Impacts of Three nC60 Dispersal Methods on E. coli Growth J. Dai, G.H. Chen, HKUST, CN | |
| - | Comparing Cytotoxicity of ZnO Nanoparticles in Exposure to Serum/Serum-free Cell Culture Medium I.L. Hsiao, Y.J. Huang, National Tsing Hua University, TW | |
| - | Uptake and distribution of inhaled carbon nanotubes characterized by Raman spectroscopy T.I. Ingle, E. Dervishi, R. Buchanan, A. Biris, Arkansas State University, US | |
| - | Elucidation of Neuroprotective Properties of Astrocytoma (Astrocytes-like) Cells in Neural Cell Culture Models In Vitro: Applications in Tissue Engineering and Nanotoxicology Y.Y.W. Wong, A. Jaiswal, V.V. Dukhande, A. Bhushan, S.W. Leung, J.C.K. Lai, Idaho State University, US | |
| - | Effect of Dynamic Environment on the Interaction between Nanoparticles and A549 Monolayer H. Patel, H. Kim, S. Kwon, Utah State University, US | |
| - | In Vitro Cytotoxicity Study of Nanomaterials: Bioimpedance Analysis Technique K. Kandasamy, M. Marimuthu, S. Kim, Kyungwon University, KR | |
| - | Determination of Histamine and Histamine-forming Bacteria in Dried Milkfish Products Implicated in a Food Borne Poisoning and Sold in Retail markets Y.H. Tsai, Y.C. Lee, National Kaohsiung Marine University, TW | |
| - | Cell damage by energy saving light bulbs T. Mironava, M.H. Rafailovich, SUNY at Stony Brook, US | |
| - | Novel Mycotoxin Collection System using Magnetic Nanoparticles for Determination of Aflatoxin B1 and Zearalenone in Feed S-H Cha, J-K Lee, H-S Jung, S-H Kim, H-J Kim, C-U Choi, H-G Kang, National Veternary Research and Quarantine Service, KR | |
| - | California’s Efforts to Safe and Responsible Nanotechnologies: Information Call-in from Manufacturers of Nanometals and Oxides H-Y Kang, California Environmental Protection Agency, US | |
| - | Potential Insurance Coverage Issues Arising from Nanotechnology: Big Risks Could Come in Small Packages A.J. Fink, Howrey LLP, US | |
| - | Cytotoxicity Assessment of Human Lung Alveolar Cell Exposed to Nanoparticles and Polycyclic Aromatic Hydrocarbons Exhausted from Motorcycle S.M. Chien, Y.J. Huang, C.C.Y. Chuang, I.L. Hsiao, Y.F. Kuo, National Tsing Hua University, TW | |
| - | The Mechanism of Mediated Electrochemical Dissolution of Semiconducting Metal Oxide Particle A. Inoue, Japan Atomic Energy Agency,Tokai, JP | |
Wednesday June 23 | ||
| Back to Top | ||
| 10:00 | Networking Coffee Break | Foyer 2nd Floor |
| Back to Top | ||
| 1:30 | Nanoparticles in Bio Imaging Technologies | Room 201 C |
| Session chair: Manuel Perez, University of Central Florida, US | ||
| 1:30 | Introduction to Nanoparticles in Bio Imaging (invited presentation) M. Perez, University of Central Florida, US | |
| 1:55 | Targeted Magnetic resonance imaging of tumors with Gd-Conjugated Dendrimer Nanoclusters (invited presentation) Z. Cheng, D.L.J. Thorek, A. Tsourkas, University of Pennsylvania, US | |
| 2:15 | Multifunctional Nanoparticles for Imaging and Therapeutics (invited presentation) X. Gao, University of Washington, US | |
| 2:35 | MR-related Nanotechnologies (invited presentation) J. Grimm, Memorial Sloan Kettering Cancer Center, US | |
| 2:55 | Picomolar Sensitivity MRI and photoacoustic imaging of cobalt nanoparticles (invited presentation) L-S. Bouchard, M. Sabieh Anwar, G.L. Liu, X. Wang, F.F. Chen, University of California, Los Angeles, US | |
| 3:15 | Molecular and Nanotechnology Imaging in Cancer Biology and Therapeutics J. Zweit, Virginia Commonwealth University, US | |
| 3:35 | Copper 64-Cu nanoparticles in multimodal imaging of carotid artery disease R. Sharma, A. Sharma, Florida State University, US | |
| 3:55 | Synchrotron radiation microtomography for the ex-vivo and in-vivo evaluation of nanoparticle-labeled stem cell homing in muscular tissue F. Fiori, A. Farini, A. Giuliani, A. Manescu, C. Villa, Y. Torrente, Polytechnic University of Marche, IT | |
| Back to Top | ||
| 4:00 | Poster Session and TechConnect Expo Reception (4:00 - 6:00) - Expo Hall | Expo Hall |
| Back to Top | ||
| 6:00 | TechConnect Innovation Showcase Reception (6:00 - 8:00) - Ballroom 3rd Floor | Ballroom BC |
Thursday June 24 | ||
| Back to Top | ||
| 8:30 | Keynotes: Transformational Nanotech | Room 303 CD |
| Session chair: Clayton Teague, NNCO, US | ||
| 8:30 | Nanotechnology: Path Toward Commercialization at GE M. Butts, General Electric, US | |
| 9:00 | Getting the Memristor to Market S. Williams, Hewlett Packard, US | |
| Back to Top | ||
| 10:00 | TechConnect Innovation Showcase Coffee Break - Ballroom 3rd Floor | Ballroom BC |
| Back to Top | ||
| 10:30 | EHS: Nanoparticle Interactions, Biocompatibility & Toxicity I | Room 201 A |
| Session chair: Rashi Iyer, Los Alamos National Labs, US | ||
| 10:30 | Modeling Aggregation and Size Distribution of Nanoparticles with Monte Carlo Simulation H.H. Liu, University of California, Los Angeles, US | |
| 10:50 | Behaviour of Aerosol Nanoparticles Released into Simulated Workplace Environment Q. Wu, S. Marion, M. Seipenbusch, G. Kasper, DNV, NO | |
| 11:10 | Interactions of Gold Nanoparticle Reference Materials with DNA in Cell-Free and Cell-Containing Systems B.C. Nelson, National Institute of Standards and Technology, US | |
| 11:30 | The Use of Nanoscale Zero Valent Iron for Environmental Remediation – Benefits and Possible Pitfalls S. Chan Remillard, M. Borda, A. Crawford, T. Kloschinsky, P. Stenroos, L. Marques, J.S. Goudey, HydroQual Ltd and Golder Associates Ltd/Inc., CA | |
| 11:50 | Ultra-Structural Analysis of the Interaction of Carboxylated Multi-Walled Carbon Nanotubes with Human Blood Platelets S.H. Lacerda, J. Semberova., K. Holada., O. Simakova, M.P. Gelderman-Fuhrmann, J. Simak, FDA, US | |
| Back to Top | ||
| 5:00 | TechConnect Investment Networking Reception - Second Floor | Foyer 2nd Floor |
Synopsis
Non-invasive imaging technologies for the diagnosis of disease typically involve the administration of contrast or signal enhancement agents that facilitate the visualization of organs or the state of a particular disease. Nanotechnology, particularly the development of nanoparticle-based agents, has had a tremendous impact in the design of targeted and specific nanoagents with the potential of homing on a particular area and interrogating for normal or disease processes. Nanoagents that interrogate at the molecular level the presence of specific molecular markers associated with the progression of diseases such as cancer and atherosclerosis are currently being developed and could potentially be used for the detection and treatment of these conditions.
This section/symposium will cover nanoparticle technologies for the visualization of disease-related markers at the molecular or cellular level using magnetic resonance imaging (MRI), optical/fluorescent imaging, X-ray computed tomography (X-ray CT), ultrasound and positron emission tomography (PET), among others.
Topics & Application Areas
- Nanoparticles for targeted imaging of disease
- Multimodal nanoparticles
- Theranostic Nanoparticles
- Magnetic Resonance Imaging (MRI)
- Fluorescence Molecular Tomography (FMT)
- X-ray Computed Tomography
- Positron Emission Tomography (PET)
- Photodynamic Therapy
- Other
Journal Submissions
Journal of Nanoparticle Research
Selected Nanotech Proceedings papers will be reviewed and invited into a Special Issue of Journal of Nanoparticle Research. The journal disseminates knowledge of the physical, chemical and biological phenomena and processes in nanoscale structures.
For consideration into this Special Issue of Journal of Nanoparticle Research, please select the “Submit to Journal of Nanoparticle Research” button during the on-line submission procedure.
Nanomedicine: Nanotechnology, Biology and Medicine (Nanomedicine)
Nanomedicine: Nanotechnology, Biology and Medicine (Nanomedicine) is a newly established, international, peer-reviewed journal published quarterly. Nanomedicine publishes basic, clinical, and engineering research in the innovative field of nanomedicine. Article categories include basic nanomedicine, diagnostic nanomedicine, experimental nanomedicine, clinical nanomedicine, and engineering nanomedicine, pharmacological nanomedicine.
For consideration into the Nanomedicine: Nanotechnology, Biology and Medicine journal please select the “Submit to Nanomedicine: Nanotechnology, Biology and Medicine” button during the on-line submission procedure.